Technology
TECHNOLOGYTHE EPINEX TECHNOLOGY PLATFORM
The Epinex G1A™ test is based on a platform technology that incorporates a capability for multiple analyte detection with quantitative measurement for each analyte.
The Epinex G1A™ Test is the first of a series of diagnostic monitoring tests based on the Company’s proprietary detection platform technology and dual-mode test reader. The Epinex system is capable of measuring analyte concentrations in blood, serum, urine or water allowing the technology a broad range of tests in medical, veterinary, food safety and environmental applications.
Our technology can be easily applied to different monitoring requirements by developing the specific analyte quantification mechanism required and applying it to our monitoring platform.
Future rapid tests under development:
- Infectious diseases
- Metabolic disorders
- Coronary artery disease
- Rheumatoid arthritis
- Down Syndrome
- Neonatal HIV